BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25646018)

  • 1. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
    Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
    Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury.
    Zhu C; Xuan X; Che R; Ding G; Zhao M; Bai M; Jia Z; Huang S; Zhang A
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1410-7. PubMed ID: 24808537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
    Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
    Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knocking down Cabin1 induces glomerular podocyte injury.
    Wen Y; Liu L; Xu Q; Zhou P; Li H; Wang Z; Liang J
    Int Urol Nephrol; 2018 May; 50(5):983-991. PubMed ID: 29368245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
    Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
    Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway.
    Dong J; Jiang Z; Ma G
    Exp Cell Res; 2020 May; 390(2):111928. PubMed ID: 32156599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss.
    Zou MS; Yu J; Nie GM; He WS; Luo LM; Xu HT
    Int J Med Sci; 2010 Aug; 7(5):290-9. PubMed ID: 20827429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP signaling prevents podocyte apoptosis via activation of protein kinase A and mitochondrial fusion.
    Li X; Tao H; Xie K; Ni Z; Yan Y; Wei K; Chuang PY; He JC; Gu L
    PLoS One; 2014; 9(3):e92003. PubMed ID: 24642777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
    BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leonurine ameliorates adriamycin-induced podocyte injury via suppression of oxidative stress.
    Liu X; Cao W; Qi J; Li Q; Zhao M; Chen Z; Zhu J; Huang Z; Wu L; Zhang B; Yuan Y; Xing C
    Free Radic Res; 2018 Sep; 52(9):952-960. PubMed ID: 30334481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
    Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
    Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversities of podocyte molecular changes induced by different antiproteinuria drugs.
    Xing Y; Ding J; Fan Q; Guan N
    Exp Biol Med (Maywood); 2006 May; 231(5):585-93. PubMed ID: 16636307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
    Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
    J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury.
    Su M; Dhoopun AR; Yuan Y; Huang S; Zhu C; Ding G; Liu B; Yang T; Zhang A
    Am J Physiol Renal Physiol; 2013 Aug; 305(4):F520-31. PubMed ID: 23761667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
    Takahashi Y; Ikezumi Y; Saitoh A
    Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of glomerular filtration barrier damage in adriamycin-induced nephropathic rats with bufalin: an antiproteinuric agent.
    Zheng J; Gong J; Zhang A; Li S; Zeng Z; Han Y; Gan W
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):107-14. PubMed ID: 22207085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β-catenin activity.
    Huang X; Xue H; Ma J; Zhang Y; Zhang J; Liu Y; Qin X; Sun C
    J Cell Mol Med; 2019 Jun; 23(6):4443-4453. PubMed ID: 30993911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.
    Lydia A; Asanuma K; Nonaka K; Takagi M; Jeong KH; Kodama F; Asao R; Asanuma E; Prodjosudjadi W; Tomino Y
    Am J Nephrol; 2012; 35(1):58-68. PubMed ID: 22189044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.